Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 11:8:739810.
doi: 10.3389/fmed.2021.739810. eCollection 2021.

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis

Affiliations
Review

Telomere Dysfunction in Idiopathic Pulmonary Fibrosis

Kexiong Zhang et al. Front Med (Lausanne). .

Abstract

Idiopathic pulmonary fibrosis is an age-dependent progressive and fatal lung disease of unknown etiology, which is characterized by the excessive accumulation of extracellular matrix inside the interstitial layer of the lung parenchyma that leads to abnormal scar architecture and compromised lung function capacity. Recent genetic studies have attributed the pathological genes or genetic mutations associated with familial idiopathic pulmonary fibrosis (IPF) and sporadic IPF to telomere-related components, suggesting that telomere dysfunction is an important determinant of this disease. In this study, we summarized recent advances in our understanding of how telomere dysfunction drives IPF genesis. We highlighted the key role of alveolar stem cell dysfunction caused by telomere shortening or telomere uncapping, which bridged the gap between telomere abnormalities and fibrotic lung pathology. We emphasized that senescence-associated secretory phenotypes, innate immune cell infiltration, and/or inflammation downstream of lung stem cell dysfunction influenced the native microenvironment and local cell signals, including increased transforming growth factor-beta (TGF-β) signaling in the lung, to induce pro-fibrotic conditions. In addition, the failed regeneration of new alveoli due to alveolar stem cell dysfunction might expose lung cells to elevated mechanical tension, which could activate the TGF-β signaling loop to promote the fibrotic process, especially in a periphery-to-center pattern as seen in IPF patients. Understanding the telomere-related molecular and pathophysiological mechanisms of IPF would provide new insights into IPF etiology and therapeutic strategies for this fatal disease.

Keywords: SASP; TGF-β; alveolar stem cells; innate immune cells; telomere dysfunction; telomere shortening.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic telomere structure and essential components. Human telomeric repeated DNA is protected by the shelterin complex, which consists of the protein components TRF1, TRF2, RAP1, TIN2, TPP1, and POT1. The ends of telomeres are bonded with telomerase, which is comprised of the catalytic subunit of TERT and the telomerase RNA component of TERC, and this exerts its effects by adding telomeric sequences to the telomeric ends. The telomerase also has other accessory components, including dyskerin, NHP2, NOP10, and GAR1. The function of these accessory components is to stabilize the TERC.
Figure 2
Figure 2
A proposed model to depict the pathogenesis of idiopathic pulmonary fibrosis caused by telomere dysfunction. Telomere dysfunction causes cellular senescence and/or cell death of alveolar epithelial type 2 cells (AEC2s), which leads to the production of a pro-fibrotic niche, mediated by the SASP. This probably leads to increased mechanical tension and a TGF-β signaling loop in a spatially distributed manner in the lung, owing to the inability to form new alveoli. Eventually, pulmonary fibrosis develops due to the significant increase in myofibroblasts.

References

    1. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet. (2011) 378:1949–61. 10.1016/S0140-6736(11)60052-4 - DOI - PubMed
    1. Fernandez IE, Eickelberg O. New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis. Lancet. (2012) 380:680–8. 10.1016/S0140-6736(12)61144-1 - DOI - PubMed
    1. du Bois RM. Idiopathic pulmonary fibrosis: present understanding and future options. Eur Respir Rev. (2011) 20:132–3. 10.1183/09059180.00001511 - DOI - PMC - PubMed
    1. Martínez P, Blasco MA. Replicating through telomeres: a means to an end. Trends Biochem Sci. (2015) 40:504–15. 10.1016/j.tibs.2015.06.003 - DOI - PubMed
    1. Smith EM, Pendlebury DF, Nandakumar J. Structural biology of telomeres and telomerase. Cell Mol Life Sci. (2020) 77:61–79. 10.1007/s00018-019-03369-x - DOI - PMC - PubMed